LeapFrog Emerging Consumer Fund IV
LeapFrog Emerging Consumer Fund IV is a global growth-equity vehicle investing in financial services and healthcare businesses serving emerging consumers, with current manager materials also showing climate investments in emerging markets. It is relevant to India-focused demand-side research because Fund IV publicly names Redcliffe Labs and the manager continues to disclose India deployment and impact evidence.
At a glance
- Founded
- 2007
- Footprint
- London / global growth markets
- Stage
- Growth equity; emerging-market financial services, healthcare and climate solutions
Research profile
Read the manager in sequence.
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
LeapFrog Emerging Consumer Fund IV uses a growth equity; emerging-market financial services, healthcare and climate solutions approach across Financial services, healthcare, climate.
Current evidence
LeapFrog reported a US$1.02 billion Fund IV close in November 2024 and published 2025–2026 impact results. In March 2026, the manager announced a US$50 million commitment to ReNew Green through its climate strategy; that manager-level transaction is not counted as a Fund IV position here.
Strategy
Growth equity; emerging-market financial services, healthcare and climate solutions
Sector focus
Financial services, healthcare, climate
Current signal
LeapFrog reported a US$1.02 billion Fund IV close in November 2024 and published 2025–2026 impact results. In March 2026, the manager announced a US$50 million commitment to ReNew Green through its climate strategy; that manager-level transaction is not counted as a Fund IV position here.
Next step
Need this manager reviewed against your mandate?
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.